FDA-OK'd Drug Offers Hope to Sickest MS Patients

WEDNESDAY, March 29, 2017 — A new multiple sclerosis drug approved by the U.S. Food and Drug Administration late Tuesday offers hope to patients with the most severe form of the progressive disease.
The intravenous drug, made by Genentech, is…
Source: Topamax